In Treatment of Melasma Melasma is a common skin problem that causes dark, discolored patches on your skin. It is more commonly seen in females than males. Gluxi TX 250mg/50mg Tablet helps to lighten these dark patches of the skin usually caused by pregnancy, birth control pills, hormone medicine, or injury to the skin. It effectively blocks that process in the skin that leads to discoloration. Gluxi TX 250mg/50mg Tablet also reduces any redness, rash, pain, or itchiness that may be caused in this condition. This improves your self-esteem and confidence as your appearance changes. You should always take it as directed by the doctor and keep taking it for as long as it is prescribed to get the full benefits.
It is not known whether it is safe to consume alcohol with Gluxi TX 250mg/50mg Tablet. Please consult your doctor.
Information regarding the use of Gluxi TX 250mg/50mg Tablet during pregnancy is not available. Please consult your doctor.
Information regarding the use of Gluxi TX 250mg/50mg Tablet during breastfeeding is not available. Please consult your doctor.
It is not known whether Gluxi TX 250mg/50mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Gluxi TX 250mg/50mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Gluxi TX 250mg/50mg Tablet may be needed. Please consult your doctor.
Gluxi TX 250mg/50mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Gluxi TX 250mg/50mg Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of Gluxi TX 250mg/50mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Alniche Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Jupiter Pharmaceutical Ltd || ₹14.5/tablet (25% cheaper)